Radiotherapy data, collection to review

Quality Matters.

In oncology trials,radiotherapy quality is a variable too.

Aitrium is the all-in-one platform for radiotherapy data collection, analysis, and review. We built it so quality assurance can be standard practice in every trial that needs it.

Every point on a survival curve is a person. When their radiotherapy varies unmeasured, the trial can misjudge the treatment.

Same drug. Two radiotherapy scenarios.Overall survival
100500Months since randomizationone patient
Radiotherapy held consistentRadiotherapy left to varyControl
Our partners
EORTC
TROG
ZAS
Our thesis

Radiotherapy itself can be a confounding variable,and too few trials control for it.

The same tumor, outlined differently. The same prescription, delivered differently. Whole regimens that shift from one patient to the next. Each difference adds noise, and noise can bury a real drug effect, or flatter a false one.

With Aitrium, sponsors can measure the impact of radiation planning quality without spending millions, and without pushing DBL deadlines.

Radiotherapy quality is not random.Unmeasured, it is bias in your efficacy data.

The data

Poor radiation quality measurably worsens survival.

01
50 vs 70%
Two-year overall survival
Head and neck patients receiving at least 60 Gy, with major RT protocol deviations versus compliant patients, inside the same phase III drug trial.
TROG 02.02 · JCO 2010 · n=87 vs 502 · HR 1.99
02
1.74×
Hazard ratio for death
When radiotherapy deviates from protocol, pooled across 8 cooperative-group trials. A median of 32% of patients were affected.
Ohri et al. · JNCI 2013 · 95% CI 1.28 to 2.35 · P < .001
03
~1 in 5
Dose delivery outside tolerance
Of 763 institutions, about 18% delivered a known dose to a test phantom outside the specified tolerance, under observation.
IROC-Houston
04
69 / 45 / 50
The commercial QA gap (%)
Of 42 phase III RT trials: only 69% mandated any QA, 45% required credentialing, 50% reported deviations.
Radiother. & Oncol. 2022
The vision

Radiotherapy quality should be measuredin every trial, every time.

Radiotherapy QA should be as routine, and as unremarkable, as the data standards drug sponsors already meet.

The precedent

CDISC began as a private data standard, built by an industry consortium and adopted by consensus, then ratified into an FDA requirement. Today you cannot get a drug approved without it. We believe radiotherapy standards can follow the same consensus-led path.

The big opportunity

Radiotherapy QA is proven.Now, it's packaged for commercial trials.

Cooperative-group trials · IROC / EORTC / TROG

Decades of QA infrastructure

  • Credentialing, phantom audits, and plan review
  • Deviation detection and reporting built in
  • A mature, trusted quality apparatus
  • but voluntary, not an FDA requirement
The commercial trials bringing drugs to market

Quality inconsistently required

  • RT quality inconsistently required across programs
  • Half never report protocol deviations
  • No FDA data-quality standard to meet
  • yet these carry the drug to approval
Our product

One platform for the entire radiotherapy trial workflow, from first upload to final read.

What made radiotherapy QA impractical at scale was the manual work between steps. Aitrium runs the entire flow as one throughline, from the first patient.

Aitrium trial management dashboard
Step 1

Data Collection

Enroll sites and patients in minutes. Automated protocol ingestion generates rich collection schedules, and a typical upload is delivered in under two minutes with validation built in.

Step 2

Analysis & Aggregation

Standardization and automated QA scorecards, with a wide range of insights generated before any human review.

Step 3

Review Workspace Automation

Adherence enforced automatically, so deviations are caught before central review. Queue, triage, and routing handled by the protocol.

Step 4

Review Environment

A reviewer-grade, protocol-informed DICOM workspace where the final read happens.

Median submission time under two minutes1 Site back-and-forth reduced by 90% A fraction of the cost of legacy central review

1. Median 98 seconds start to finish, including user review; median active processing 41 seconds. 54 production submissions across 10 clinical institutions in 6 countries (March to July 2026), measured from platform audit telemetry.

Security & compliance

Patient data stays between your sites and your sponsors.

Data is sent directly from the providing center to the sponsor's secure FTP, over channels your teams have already secured, reviewed, and approved. Aitrium orchestrates the workflow around that transfer: the protocol, the validation, the audit trail. Never the images themselves.

That architecture is deliberate. It leverages the security work your organizations have already done instead of adding to it: no new custodian of your images, no third-party image store to assess, no additional hop between your sites and your sponsors.

  • Built to operate under GDPR, HIPAA, and privacy frameworks worldwide
  • All data encrypted in transit and at rest
  • Role-based access control down to the trial level
  • Comprehensive audit logging for every data-submission action

Learn more about our trust and security architecture →

🏥
Providing center
Site of care
encrypted
🔒
Sponsor secure FTP
Destination
Aitrium sits alongside the transfer, orchestrating protocol, validation, and audit. Never in the image path.

Quality Matters.

For the integrity of your data.
For the people counting on it.

Request a demo
Aitrium